An effort to develop technology to enroll a portion of the 1 million volunteers in the White House's Precision Medicine Initiative is placing a spotlight on one possible solution to interoperability and in the meantime creating unprecedented collaboration.
McKesson Corp. is cutting its workforce by 4% or about 1,600 jobs and refining its strategy to lower costs. The plan should save the drug distributor $170 million to $190 million before taxes in fiscal 2017, as well as incremental savings of $70 million to $90 million in 2018.
Hospital systems now routinely deal with an uncomfortable number of drug shortages, so they're forging direct relationships with manufacturers, and buying directly from the source when the usual channels dry up.
One of the frustrating things about healthcare data is that they live in silos, so the user experience is far from seamless. But that's becoming unacceptable with the growth of high-deductible health plans and the corresponding wave of healthcare consumerism.
Prescription drug distributor McKesson Corp. is buying Canadian pharmacy operator Rexall Health from Katz Group for $2.2 billion, strengthening McKesson's Canadian pharmaceutical supply chain.
BlackRock, the world's largest asset manager, is placing big bets on healthcare stocks. The giant New York money manager, which oversees more than $4.5 trillion in assets, took large positions last year in at least 14 investor-owned healthcare companies and a host of medical-device and equipment...
Hospital systems that have acquired physician practices and outpatient treatment centers are wrestling with how to integrate them into their existing supply-chain distribution system. The goal is to extend the low prices achieved through bulk purchasing to these geographically dispersed facilities.
McKesson Corp. reported a profit jump in its third quarter, thanks to lower foreign taxes and growth in its North American pharmaceutical distribution and services.
In light of the challenges seen since President Nixon launched the first "war on cancer" in 1971, experts say any new approach to cures, moonshot or otherwise, must get back to the basics. The oncology community agrees a coordinated approach could address the clinical research challenges.
Healthcare giant McKesson Corp. reported a jump in earnings in its second quarter thanks to strong distribution revenue, lower-than-expected taxes and the sale of its workplace-safety supply business.
Healthcare giant McKesson Corp. has announced that it will acquire the pharmaceutical distribution of UDG Healthcare.
At the center of the huge U.S. drug research enterprise sit some of its lowest-paid workers, who do the data-entry scut work that holds most research projects together. Unfortunately, they often must juggle their tasks between separate data systems.